| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. | -1.21% | 0.62% | 18.84% | -25.43% | -40.18% | 4 705 |
| | | | | | | |
 | CSL LIMITED | -0.48% | -1.44% | 2.41% | 18.15% | -5.15% | 101 009 |
 | SAMSUNG BIOLOGICS CO.,LTD. | 1.76% | 1.00% | -1.46% | 13.62% | 67.49% | 46 755 |
 | BIOGEN INC. | -0.63% | 1.51% | 4.75% | 32.49% | 3.18% | 41 772 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -0.63% | -0.56% | 18.55% | -8.10% | 103.68% | 38 289 |
| BIOMARIN PHARMACEUTICAL INC. | 0.25% | 5.89% | 13.32% | 41.20% | 38.58% | 21 795 |
 | UCB | 1.02% | -1.93% | 2.42% | -14.11% | -7.40% | 15 536 |
| INNOVENT BIOLOGICS, INC. | 1.73% | 9.05% | 40.30% | 40.51% | 50.16% | 9 211 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | 0.97% | -3.37% | -14.23% | -9.57% | 65.74% | 8 323 |
 | GRIFOLS, S.A. | -0.28% | 3.17% | 16.30% | -20.32% | -59.60% | 8 109 |
| CELLTRION HEALTHCARE CO., LTD. | 0.51% | 1.72% | 2.24% | 2.79% | 16.24% | 7 768 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 0.70% | 0.78% | 7.37% | 28.99% | 31.37% | 6 642 |
| APELLIS PHARMACEUTICALS, INC. | -0.02% | 1.38% | 2.05% | 41.78% | 30.72% | 5 830 |
| SK BIOSCIENCE CO.,LTD. | 4.56% | 4.02% | 9.25% | -50.12% | --.--% | 5 007 |
| ZAI LAB LIMITED | 0.92% | -1.43% | 46.19% | 6.83% | -17.06% | 4 307 |
| ABCAM PLC | -1.91% | 0.43% | 5.59% | -3.30% | --.--% | 3 761 |
| | | | | | | |
| | Durchschnitt | 0.56% | 1.35% | 10.34% | 8.06% | 24.46% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.17% | 0.51% | 6.61% | 14.03% | 26.73% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
